Baril Corporation

Baril Corporation is a medical device manufacturing company dedicated to developing innovative products that enhance safety for patients and caregivers within the healthcare sector. Their focus includes vital diagnostics and infection control solutions. Founded in 1972 and headquartered in Haverhill, US, Baril Corporation specializes in medical device manufacturing. In August 2020, the company was acquired by Team Technologies, Inc.

, a portfolio company of Clearlake Capital Group, enhancing its operational capabilities. Daniel Baril serves as the CEO, leading the company through its strategic initiatives. Baril Corporation offers a range of medical device solutions, including In Vitro Diagnostic (IVD) tests, wearable patient monitoring sensors, and infection control products. These innovations are designed to address critical challenges in healthcare, improving wound care techniques and ensuring accurate medication delivery to enhance safety and efficiency for healthcare providers and patients alike.

Baril Corporation operates primarily on a business-to-business (B2B) model, supplying medical devices directly to healthcare institutions and manufacturers. Revenue is generated from the sale of specialized products, such as the UnoDose™ single-use metered dosing applicators. The pricing is based on product type and order volume, often leading to long-term contracts with clients to ensure consistent supply. Following the acquisition in August 2020, Baril Corporation aims to launch several new products within the next 12 to 18 months, focusing on enhancing patient safety.

The company plans to expand its market presence beyond North America to select international regions, targeting growth initiatives that leverage recent funding for increased production capacity and R&D efforts.